Hepatitis G virus

World Journal of Gastroenterology

Volumn 14, Issue 30, 2008, Pages 4725-4734

  Reshetnyak, Vasiliy Ivanovich ^a   Karlovich, Tatiana Igorevna ^b   Ilchenko, Ljudmila Urievna ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

Author keywords

Clinical manifestations; Epidemiology; Hepatitis G virus; Markers of GBV C

Indexed keywords

HEPATITIS VACCINE; VIRUS RNA; HEPATITIS ANTIBODY;

ANTIBODY DETECTION; BILIARY TRACT DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE MARKER; DRUG TARGETING; EDITORIAL; GENETIC SIMILARITY; GENOTYPE; HEMATOLOGIC DISEASE; HEPATITIS B; HEPATITIS C; HEPATITIS G; HEPATITIS G VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LITERATURE; MIXED INFECTION; NONHUMAN; PREVALENCE; PROGNOSIS; TAXONOMY; VIRUS MORPHOLOGY; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE; BLOOD; CLASSIFICATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HISTORY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; PATHOLOGY; PLANT GROWTH; VIROLOGY; VIRUS GENOME; VIRUS HEPATITIS; VIRUS LOAD;

GB VIRUS C; GENOME, VIRAL; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS, VIRAL, HUMAN; HISTORY, 20TH CENTURY; HUMANS; LIVER; RNA, VIRAL; TROPISM; VIRAL LOAD; VIRUS REPLICATION;

EID: 55449104651     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4725     Document Type: Editorial

References (127)

1. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-3405
2. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JW, Young L, Piatak M Jr, Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SK, Thomas H, Bradley D, Margolis H, Kim JP. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-508
3. Balayan MS, Poleshchuk VF. Viral hepatitis in primates: experimental reproduction and natural infection. Virusnye hepatity (Viral hepatitides) 1998; 3: 3-12
4. Maidana MT, Sabino EC, Kallas EG. GBV-C/HGV and HIV-1 coinfection. Braz J Infect Dis 2005; 9: 122-125
5. Robertson BH. Viral hepatitis and primates: historical and molecular analysis of human and nonhuman primate hepatitis A, B, and the GB-related viruses. J Viral Hepat 2001; 8: 233-242
6. Okamoto H, Nakao H, Inoue T, Fukuda M, Kishimoto J, Iizuka H, Tsuda F, Miyakawa Y, Mayumi M. The entire nucleotide sequences of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan. J Gen Virol 1997; 78 (Pt 4): 737-745
7. Tucker TJ, Smuts HE. GBV-C/HGV genotypes: proposed nomenclature for genotypes 1-5. J Med Virol 2000; 62: 82-83
8. Novikov DV. Molecular biological characteristics of HCV. Abstract of dissertation for Candidate of Medical Sciences. 2000: 1-22
9. Muerhoff AS, Dawson GJ, Desai SM. A previously unrecognized sixth genotype of GB virus C revealed by analysis of 5′-untranslated region sequences. J Med Virol 2006; 78: 105-111
10. Viazov S, Riffelmann M, Khoudyakov Y, Fields H, Varenholz C, Roggendorf M. Genetic heterogeneity of hepatitis G virus isolates from different parts of the world. J Gen Virol 1997; 78 (Pt 3): 577-581
11. Mikhailov MI. Hepatitis G: problems of studies. Virus hepat 1997; 1: 3-11
12. Stapleton JT, Williams CF, Xiang J. GB virus type C: a beneficial infection? J Clin Microbiol 2004; 42: 3915-3919
13. Nakao H, Okamoto H, Fukuda M, Tsuda F, Mitsui T, Masuko K, Iizuka H, Miyakawa Y, Mayumi M. Mutation rate of GB virus C/hepatitis G virus over the entire genome and in subgenomic regions. Virology 1997; 233: 43-50
14. Kim JP, Fry KE. Molecular characterization of the hepatitis G virus. J Viral Hepat 1997; 4: 77-79
15. Bassit L, Kleter B, Ribeiro-dos-Santos G, Maertens G, Sabino E, Chamone D, Quint W, Saez-Alquezar A. Hepatitis G virus: prevalence and sequence analysis in blood donors of Sao Paulo, Brazil. Vox Sang 1998; 74: 83-87
16. Schaluder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Gutierrez RA, Heynen CA, Knigge MF, Kurpiewski GS, Buijk SL, Leary TP. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 1995; 46: 81-90
17. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60-67
18. Marmor M, Hertzmark K, Thomas SM, Halkitis PN, Vogler M. Resistance to HIV infection. J Urban Health 2006; 83: 5-17
19. Pessoa MG, Terrault NA, Detmer J, Kolberg J, Collins M, Hassoba HM, Wright TL. Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 1998; 27: 877-880
20. Kudo T, Morishima T, Shibata M. Hepatitis G infection. N Engl J Med 1997; 337: 276-277
21. Souza IE, Allen JB, Xiang J, Klinzman D, Diaz R, Zhang S, Chaloner K, Zdunek D, Hess G, Williams CF, Benning L, Stapleton JT. Effect of primer selection on estimates of GB virus C (GBV-C) prevalence and response to antiretroviral therapy for optimal testing for GBV-C viremia. J Clin Microbiol 2006; 44: 3105-3113
22. Laras A, Zacharakis G, Hadziyannis SJ. Absence of the negative strand of GBV-C/HGV RNA from the liver. J Hepatol 1999; 30: 383-388
23. Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication. Arch Virol 1999; 144: 2173-2183
24. Zampino R, Pickering J, Iqbal M, Gaud U, Thomas HC, Karayiannis P. Hepatitis G virus/GBV-C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes. J Viral Hepat 1999; 6: 209-218
25. Handa A, Brown KE. GB virus C/hepatitis G virus replicates in human haematopoietic cells and vascular endothelial cells. J Gen Virol 2000; 81: 2461-2469
26. Hwang SJ, Lu RH, Chan CY, Chang FY, Lee SD. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis. J Med Virol 1999; 57: 85-89
27. Ilchenko LYu, Sharafanova TI, Shepeleva SD, Serova TI. Antibodies to hepatitis G virus in patients with chronic liver diseases. Hepatology 2003; 5: 4-6
28. Loginov AS, Sharafanova TI, Reshetniak VI, Il'chenko Llu, Shepeleva SD, Serova TI, Tkachev VD. [HGV and TTV - new hepatitis viruses] Ter Arkh 2000; 72: 9-13
29. Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, Nelson KE. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998; 177: 539-542
30. Yang JF, Dai CY, Chuang WL, Lin WY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Tsai JF, Chang WY, Yu ML. Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C. Jpn J Infect Dis 2006; 59: 25-30
31. Wachtler M, Hofmann A, Muller G, Frosner G, Nitschko H, Karwat M, Knetsch I, Emminger C, Eichenlaub D. Prevalence of GB virus C/hepatitis G virus RNA and anti-E2 glycoprotein antibodies in homosexual men with HIV coinfection. Infection 2000; 28: 297-300
32. Rey D, Vidinic-Moularde J, Meyer P, Schmitt C, Fritsch S, Lang JM, Stoll-Keller F. High prevalence of GB virus C/hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2000; 19: 721-724
33. Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-1355
34. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW, Kim JP. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754
35. de Lamballerie X, Charrel RN, Dussol B. Hepatitis GB virus C in patients on hemodialysis. N Engl J Med 1996; 334: 1549
36. Lefrere JJ, Sender A, Mercier B, Mariotti M, Pernot F, Soulie JC, Malvoisin A, Berry M, Gabai A, Lattes F, Galiay JC, Pawlak C, de Lachaux V, Chauveau V, Hreiche G, Larsen M, Ferec C, Parnet-Mathieu F, Roudot-Thoraval F, Brossard Y. High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donors. Transfusion 2000; 40: 602-607
37. Guilera M, Sáiz JC, López-Labrador FX, Olmedo E, Ampurdanés S, Forns X, Bruix J, Parés A, Sánchez-Tapias JM, Jimenez de Anta, Rodes J. Hepatitis G virus infection in chronic liver disease. Gut 1998; 42: 107-111
38. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, Inoue T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-1490
39. Kalkan A, Ozdarendeli A, Bulut Y, Saral Y, Ozden M, Kelestimur N, Toraman ZA. Prevalence and genotypic distribution of hepatitis GB-C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in eastern Anatolia, Turkey. Jpn J Infect Dis 2005; 58: 222-227
40. Mastouri M, Safer IL, Pozzetto B, Bourlet T, Khedher M. [Prevalence of hepatitis G virus among Tunisian blood donors] East Mediterr Health J 2005; 11: 1053-1060
41. Grabarczyk P, Brojer E, Windyga J, Lopaciuk S, Klukowska A, Mikulska M. [GBV-C/HGV and TTV infection markers in Polish blood donors and haemophilia patients] Przegl Epidemiol 2006; 60: 581-588
42. Wiwanitkit V. Hepatitis G virus RNA positivity among the voluntary blood donors: a summary. Ann Hepatol 2005; 4: 43-46
43. Dencs A, Sebestyen A. Prevalence and genotypes of hepatitis G virus/GB virus C in a multirisk group in Hungary. Acta Microbiol Immunol Hung 2007; 54: 305-316
44. Barusruk S, Urwijitaroon Y. High prevalence of HGV coinfection with HBV or HCV among northeastern Thai blood donors. Southeast Asian J Trop Med Public Health 2006; 37: 289-293
45. Bouchardeau F, Laperche S, Pillonel J, Elghouzzi MH, Maisonneuve P, Tirtaine C, Boiret E, Razer A, Girault A, Beaulieu MJ, Courouce AM. GB virus type C/HGV markers in HCV RNA-positive French blood donors: correlation with HCV genotypes and risk factors. Transfusion 2000; 40: 875-878
46. Karayiannis P, Pickering J, Chiaramonte M, Thomas HC. Hepatitis G virus infection. Lancet 1997; 349: 954
47. Martin P, Fabrizi F, Dixit V, Brezina M, Gerosa S, Russell J, Conrad A, Gitnick G. Epidemiology and natural history of hepatitis G virus infection in chronic hemodialysis patients. Am J Nephrol 1999; 19: 535-540
48. Rubio A, Rey C, Sanchez-Quijano A, Leal M, Pineda JA, Lissen E, Hess G. Is hepatitis G virus transmitted sexually? JAMA 1997; 277: 532-533
49. Miyakawa Y, Mayumi M. Hepatitis G virus - a true hepatitis virus or an accidental tourist? N Engl J Med 1997; 336: 795-796
50. Kumar D, Arora A, Singh NP, Kohli R, Kar P, Das BC. Hepatitis G virus infection in hemodialysis patients from urban Delhi. Ren Fail 2005; 27: 87-93
51. Kachko AV, Ershov AE, Gavrilova IV, Shustov AV, Kochneva GV, Sivolobova GF, Grazhdantseva AA, Bukin VN, Komissarova MA, Netesov SV. [The occurrence rate of HGV/GBV-C RNA and risk factors in patients of narcological dispensary in Novosibirsk] Zh Mikrobiol Epidemiol Immunobiol 2005; 25-30
52. Stark K, Doering CD, Bienzle U, Pauli G, Hamouda O, Engel AM, Schreier E. Risk and clearance of GB virus C/hepatitis G virus infection in homosexual men: A longitudinal study. J Med Virol 1999; 59: 303-306
53. Sawayama Y, Hayashi J, Etoh Y, Urabe H, Minami K, Kashiwagi S. Heterosexual transmission of GB virus C/hepatitis G virus infection to non-intravenous drug-using female prostitutes in Fukuoka, Japan. Dig Dis Sci 1999; 44: 1937-1943
54. Yeo AE, Matsumoto A, Shih JW, Alter HJ, Goedert JJ. Prevalence of hepatitis G virus in patients with hemophilia and their steady female sexual partners. Sex Transm Dis 2000; 27: 178-182
55. Ohto H, Ujiie N, Sato A, Okamoto H, Mayumi M. Mother-to-infant transmission of GB virus type C/HGV. Transfusion 2000; 40: 725-730
56. Wejstal R, Manson AS, Widell A, Norkrans G. Perinatal transmission of hepatitis G virus (GB virus type C) and hepatitis C virus infections - a comparison. Clin Infect Dis 1999; 28: 816-821
57. Palomba E, Bairo A, Tovo PA. High rate of maternal-infant transmission of hepatitis G virus in HIV-1 and hepatitis C virus-infected women. Acta Paediatr 1999; 88: 1392-1395
58. Halasz R, Fischler B, Nemeth A, Lundholm S, Sallberg M. A high prevalence of serum GB virus C/hepatitis G virus RNA in children with and without liver disease. Clin Infect Dis 1999; 28: 537-540
59. Mphahlele MJ, Aspinall S, Spooner R, Carman WF. Age related prevalence of hepatitis G virus in South Africans. J Clin Pathol 1999; 52: 752-757
60. Xiang J, Wunschmann S, Schmidt W, Shao J, Stapleton JT. Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 2000; 74: 9125-9133
61. Sheng L, Soumillion A, Beckers N, Wu CG, Verslype C, Nevens F, Pirenne J, Aerts R, Kosala H, Fevery J, Yap SH. Hepatitis G virus infection in acute fulminant hepatitis: prevalence of HGV infection and sequence analysis of a specific viral strain. J Viral Hepat 1998; 5: 301-306
62. Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczynski K, Kim JP, Margolis HS. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med 1997; 336: 741-746
63. Romano L, Fabris P, Tanzi E, Tositti G, Mazzotta F, Zanetti AR. GBV-C/hepatitis G virus in acute nonA-E hepatitis and in acute hepatitis of defined aetiology in Italy. J Med Virol 2000; 61: 59-64
64. Chu CM, Lin SM, Hsieh SY, Yeh CT, Lin DY, Sheen IS, Liaw YF. Etiology of sporadic acute viral hepatitis in Taiwan: the role of hepatitis C virus, hepatitis E virus and GB virus-C/hepatitis G virus in an endemic area of hepatitis A and B. J Med Virol 1999; 58: 154-159
65. Parana R, Vitvitski L, Andrade Z, Trepo C, Cotrim H, Bertillon P, Silva F, Silva L, de Oliveira IR, Lyra L. Acute sporadic non-A, non-B hepatitis in Northeastern Brazil: etiology and natural history. Hepatology 1999; 30: 289-293
66. Cheng Y, Zhang W, Li J, Li B, Zhao J, Gao R, Xin S, Mao P, Cao Y. Serological and histological findings in infection and transmission of GBV-C/HGV to macaques. J Med Virol 2000; 60: 28-33
67. Loginov AS, Lvov DK, Sharafanova TI, Tikhomirov EE, Ilchenko LY, Reshetnyak VI, Tkachev VD. Detection of hepatitis G virus (HGV) in chronic liver diseases. Ros Gastroenterol Zhurn 1999; 1: 23-31
68. Lang Z, Fang D, Luo Z. [Detection of HGV NS5 antigen in liver tissue of patients with chronic liver disease] Zhonghua Yixue Zazhi 1998; 78: 598-600
69. Berg T, Muller AR, Platz KP, Hohne M, Bechstein WO, Hopf U, Wiedenmann B, Neuhaus P, Schreier E. Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication. Hepatology 1999; 29: 245-249
70. Stransky J. [The discovery of hepatitis G virus] Cas Lek Cesk 1996; 135: 99-101
71. Kobayashi T, Ishii M, Niitsuma H, Kikuchi K, Suzuki C, Gama H, Kobayashi K, Ueno Y, Toyota T. Genoepidemiology and pathogenicity of hepatitis G virus in Japan. Tohoku J Exp Med 1997; 183: 101-112
72. Sarrazin C, Herrmann G, Roth WK, Lee JH, Marx S, Zeuzem S. Prevalence and clinical and histological manifestation of hepatitis G/ GBV-C infections in patients with elevated aminotransferases of unknown etiology. J Hepatol 1997; 27: 276-283
73. Fan X, Xu Y, Solomon H, Ramrakhiani S, Neuschwander-Tetri BA, Di Bisceglie AM. Is hepatitis G/GB virus-C virus hepatotropic? Detection of hepatitis G/GB virus-C viral RNA in liver and serum. J Med Virol 1999; 58: 160-164
74. Radkowski M, Wang LF, Vargas H, Rakela J, Laskus T. Lack of evidence for GB virus C/hepatitis G virus replication in peripheral blood mononuclear cells. J Hepatol 1998; 28: 179-183
75. Orii K, Tanaka E, Rokuhara A, Maruyama A, Ichijo T, Yoshizawa K, Kiyosawa K. Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus. Intervirology 2000; 43: 139-145
76. Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians. HIV Med 2006; 7: 25-31
77. Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001; 345: 707-714
78. Fogeda M, Navas S, Martín J, Casqueiro M, Rodríguez E, Arocena C, Carreño V. In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol 1999; 73: 4052-4061
79. Toyoda H, Takahashi I, Fukuda Y, Hayakawa T, Takamatsu J. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia. J Med Virol 2000; 60: 34-38
80. Arican A, Sengezer T, Bozdayi M, Bozkaya H, Ucgul E, Dincol D, Uzunalimoglu O. Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma. Med Oncol 2000; 17: 123-126
81. Wiwanitkit V. Individuals with HGV-RNA are at high risk of B cell non-Hodgkin's lymphoma development. Asian Pac J Cancer Prev 2005; 6: 215-216
82. Pavlova BG, Heinz R, Selim U, Tuchler H, Pittermann E, Eder G. Association of GB virus C (GBV-C)/hepatitis G virus (HGV) with haematological diseases of different malignant potential. J Med Virol 1999; 57: 361-366
83. Crespo J, de las Heras B, Rivero M, Lozano JL, Fabrega E, Pons-Romero F. Hepatitis G virus infection as a possible causative agent of community-acquired hepatitis and associated aplastic anaemia. Postgrad Med J 1999; 75: 159-160
84. Tribl B, Schoniger-Hekele M, Petermann D, Bakos S, Penner E, Muller C. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis. Am J Gastroenterol 1999; 94: 3336-3340
85. Heringlake S, Tillmann HL, Cordes-Temme P, Trautwein C, Hunsmann G, Manns MP. GBV-C/HGV is not the major cause of autoimmune hepatitis. J Hepatol 1996; 25: 980-984
86. Kao JH, Chen PJ, Wang JT, Lai MY, Chen DS. Blood-bank screening for hepatitis G. Lancet 1997; 349: 207
87. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996; 334: 1536-7
88. Yashina TL, Favorov MO, Khudyakov YE, Fields HA, Znoiko OO, Shkurko TV, Bonafonte T, Sevall JS, Agopian MS, Peter JB. Detection of hepatitis G virus (HGV) RNA: clinical characteristics of acute HGV infection. J Infect Dis 1997; 175: 1302-1307
89. Uchaikin VF, Stepanov AN, Chuyelov SB. Prevalence and clinical manifestations of virus hepatitis G in children. Ros Zhurn Gastroenterol Gepatol Koloproktol 2000; 4: 74-76
90. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132
91. Pessoa MG, Wright TL. Hepatitis G virus: what is the next step? Liver Transpl Surg 1997; 3: 677-679
92. Di Bisceglie AM. Hepatitis G virus infection: a work in progress. Ann Intern Med 1996; 125: 772-773
93. Il'chenko LIu, Sharafanova TI, Tsaregorodtseva TM, Shepeleva SD, Tkachev VD. [Chronic liver diseases associated with hepatitis G and TT viruses] Eksp Klin Gastroenterol 2002; 66-71
94. Berasain C, Betes M, Panizo A, Ruiz J, Herrero JI, Civeira MP, Prieto J. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 2000; 47: 429-435
95. Colombatto P, Randone A, Civitico G, Monti Gorin J, Dolci L, Medaina N, Oliveri F, Verme G, Marchiaro G, Pagni R, Karayiannis P, Thomas HC, Hess G, Bonino F, Brunetto MR. Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: a specific liver disease? [corrected] J Viral Hepat 1996; 3: 301-306
96. Sáiz JC, Ampurdanés S, Olmedo E, López-Labraclor FX, Forns X. Guilera M, Tassies D, Costa J, Sánchez-Tapias JM, Jiménez de Anta MT, Rodés J. Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy. J Hepatol 1997, 26: 787-793
97. Fattovich G, Ribero ML, Favarato, S, Azzario F, Donato F, Giustina G, Fasola M, Pantalena M, Portera G, Tagger A. Influence of GB virus-C/ hepatitis G virus infection on the long-term course of chronic hepatitis B. Liver 1998; 18: 360-365
98. Vargas HE, Laskus T, Radkowski M, Poutous A, Wang LF, Lee R, Dodson F, Gayowski T, Singh N, Marino IR, Fung JJ. Zhang-Keck ZY, Kim JP, Rakela J. Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation 1997; 64: 786-788
99. Ilchenko LYu, Karlovich TI. Clinical and virological features ofmixed hepatitis. Treatises of the MP. Mikhailov MJ. editor. Materials of Chumakov Institute of Poliomyelitis and Viral Encephalitis, RAMS, 2007: 297-302
100. Sharafanova TI, Reshethyak VI, Ilchenko LU. Viral C hepatitis, this is associated with others hepatotropic. Poster board presentation 79 (abstract 1532) at the 36th Annual Meeting of the European Association for the Study of the Liver (EASL); 2001 April 18-22; Prague, Czech Republic. J Hiepatol 2001; 34 suppl 1: A1532
101. Ilchenko LYu, Sharafanova TI, Vinnitskaya YeV, Shepeleva SD, Makaryeva YeD. Biliary pathology in patients infected with hepatitis G and TT viruses. Poster board presentation 61 (abstract 174) of the 4th Russian Scientific Forum "Saint Petersburg-Gastro-2002"; 2002 September 17-20; Saint Petersburg, Russia. Gastrobulleten 2002, 2 (3): A17,.
102. Chekmazov IA, Ilchenko LYu, Karlovich TI, Khomeriki SG, Silvestrova SYu, Morozov IA, Morozov DV. Hepatitis G (HGV) and TT (TTV) viruses in patients with cholelithiasis (provisional data). Hepatology 2005; 1: 37-41
103. Kumar D, Gupta RK, Anand R, Pasha ST, Rai A, Das BC, Kar P. Occurrence & nucleotide sequence analysis of hepatitis G virus in patients with acute viral hepatitis & fulminant hepatitis. Indian J Med Res 2007; 125: 752-755
104. Kao JH, Chen PJ, Wang JT, Lai MY, Chen DS. Blood-bank screening for hepatitis G. Lancet 1997; 349: 207
105. Fabris P, Infantolino D, Biasin MR, Benedetti P, Tositti G, Bettini C, Marchelle G, de Lalla F. HGV/GBV-C infection in patients with acute hepatitis of different etiology and in patients with chronic hepatitis C. J Gastroenterol 1998; 33: 57-61
106. Bychenko DV, Cheshik SG, Malyshev NA. Diagnosis and clinical evaluation of HGV infection in patients with parenteral viral hepatitides-HBV, HCV and HBV/HCV. Mir Virusnikh Gepatitov 2003; 1: 9-13
107. Tanaka E, Tacke M, Kobayashi M, Nakatsuji Y, Kiyosawa K, Schmolke S, Engel AM, Hess G, Alter HJ. Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic. J Clin Microbiol 1998; 36: 110-114
108. Moriyama M, Matsumura H, Shimizu T, Shioda A, Kaneko M, Saito H, Miyazawa K, Tanaka N, Sugitani M, Komiyama K, Arakawa Y. Hepatitis G virus coinfection influences the liver histology of patients with chronic hepatitis C. Liver 2000; 20: 397-404
109. Enomoto M, Nishiguchi S, Fukuda K, Kuroki T, Tanaka M, Otani S, Ogami M, Monna T. Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa. Hepatology 1998; 27: 1388-1393
110. Slimane SB, Albrecht JK, Fang JW, Goodman Z, Mizokami M, Qian K, Lau JY. Clinical, virological and histological implications of GB virus-C/hepatitis G virus infection in patients with chronic hepatitis C virus infection: a multicentre study based on 671 patients. J Viral Hepat 2000; 7: 51-55
111. Quintero D, Salmerón J, Palacios A, Muñoz de Rueda P, Torres C, Rodríguez L, Caballero t, Ruiz Extremera A. [Coinfection with hepatitis G virus in chronic hepatitis c. Response to treatment with interferon alpha] Med Clin (Bare) 2000; 114: 726-729
112. Fujisawa T, Horiike N, Michitaka K, Onji M. Influence of RNA titre and amino acid changes in the NS5A region of GB virus c/hepatitis G virus on the effectiveness of interferon therapy. J Gastroenterol Hepatol 2000; 15: 632-639
113. McHutchison JG, Nainan OV, Alter MJ, Sedghi-Vaziri A, Detmer J, Collins M, Kolberg J. Hepatitis C and G coinfection: response to interferon therapy and quantitative changes in serum HGV-RNA. Hepatology 1997; 26: 1322-1327
114. García F Jr, García F, Roldán C, López I, Martínez NM, Alvarez M, Bernal MC, Hernandez J, Maroto MC. Detection of HCV and GBV-CHGV RNA in peripheral blood mononuclear cells of patients with chronic type C hepatitis. Microbios 2000; 103: 7-15
115. Orito E, Mizokami M, Yasuda K, Sugihara K, Nakamura M, Mukaide M, Ohba KI, Nakano T, Kato T, Kondo Y, Kumada T, Ueda R, Iino S. Interferon-alpha therapy in patients dually infected with hepatitis C virus and GB virus C/hepatitis G virus - virological response of HGV and pretreatment HGV viremia level. J Hepatol 1997; 27: 603-612
116. Pramoolsinsap C, Sirikulchayanonta V, Busakorn W, Poovorawan Y, Hirsch P, Theamboonlers A, Lerdverasirikul P. Coinfections with hepatitis g and/or c virus in hepatitis B-related chronic liver disease. Southeast Asian J Trop Med Public Health 1999; 30: 741-749
117. Szaflarska-Szczepanik A, Loe E, Krenska-Wiacek A, Chrobot A. [Chronic hepatitis C in a 12-year-old girl coinfected with HGV] Pol Merkur Lekarski 1999; 7: 21-22
118. Al-Ahdal MN, Rezeig MA, Kessie G, Chaudhry F, Al-Shammary FJ. GB virus C/hepatitis G virus infection in Saudi Arabian blood donors and patients with cryptogenic hepatitis. Arch Virol 2000; 145: 73-84
119. Jain A, Kar P, Gopalkrishna V, Gangwal P, Katiyar S, Das BC. Hepatitis G virus (HGV) infection & its pathogenic significance in patients of cirrhosis. Indian J Med Res 1999; 110: 37-42
120. Hoofnagle JH, Lombardero M, Wei Y, Everhart J, Wiesner R, Zetterman R, Yun AJ, Yang L, Kim JP. Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database. Liver Transpl Surg 1997; 3: 578-585
121. Yuan JM, Govindarajan S, Ross RK, Yu MC. Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California. Cancer 1999; 86: 936-943
122. Yuan JM, Govindarajan S, Gao YT, Ross RK, Yu MC. Prospective evaluation of infection with hepatitis G virus in relation to hepatocellular carcinoma in Shanghai, China. J Infect Dis 2000; 182: 1300-1303
123. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345: 715-724
124. Maidana MT, Sabino EC, Kallas EG. GBV-C/HGV and HIV-1 coinfection. Braz J Infect Dis 2005; 9: 122-125
125. Xiang J, McLinden JH, Chang Q, Kaufman TM, Stapleton JT. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci USA 2006; 103: 15570-15575
126. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 2004; 363: 2040-2046
127. Xiang J, Klinzman D, McLinden J, Schmidt WN, LaBrecque DR, Gish R, Stapleton JT. Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol 1998; 72: 2738-2744